Kate Blanchard is the founder of ORIG3N. ORIG3N has raised $112M in total funding. Latest round: Series B. Backed by LabCorp. Based in Boston, USA.
Kate Blanchard is a founder and Chief Operating Officer (COO) of ORIG3N, a Boston-based biotechnology company. She co-founded the company in 2014 with Robin Smith to develop personalized regenerative medicine treatments based on patient genetic profiles. ORIG3N operates a regenerative medicine laboratory in Boston's Innovation District and has built the world's largest HLA-matched regenerative cell bank for research.
Full founder directory · Investor directory · Company funding database · Fundraising library